4//SEC Filing
TIGER MANAGEMENT L.L.C. 4
Accession 0000919574-19-001006
CIK 0001626199other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 1:52 PM ET
Size
5.8 KB
Accession
0000919574-19-001006
Insider Transaction Report
Form 4
TIGER MANAGEMENT L.L.C.
10% Owner
Transactions
- Sale
Common Stock
2019-02-08$5.85/sh−25,000$146,245→ 137,728 total(indirect: See Footnote)
Footnotes (1)
- [F1]The securities are held in the account of Tiger Partners Trading LLC which is wholly owned by Tiger Partners, L.P. and may be deemed to be beneficially owned by (a) Tiger Management L.L.C., the investment manager of Tiger Partners, L.P., and (b) Tiger Partners GP, LLC, the general partner of Tiger Partners, L.P. Each of Tiger Partners, L.P., Tiger Management L.L.C. and Tiger Partners GP, LLC disclaims beneficial ownership of these reported securities except to the extent of its pecuniary interest therein and affirmatively disclaims being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
Documents
Issuer
ALPINE IMMUNE SCIENCES, INC.
CIK 0001626199
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001027451
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 1:52 PM ET
- Size
- 5.8 KB